CytomX Therapeutics, Inc. (CTMX:NASDAQ) rocketted at $1.6, a gain of 32.2%. On Thu, Nov 17, 2022, CTMX:NASDAQ touched a New 2-Week High of $1.6. The stock appeared on our News Catalysts scanner on Thu, Nov 17, 2022 at 03:26 PM in the 'BIOTECH' category. From Thu, Nov 03, 2022, the stock recorded 50.00% Up Days and 63.64% Green Days
The stock spiked on Wed, Jul 06, 2022 at $2.01 with a volume of 1M+.
About CytomX Therapeutics, Inc. (CTMX:NASDAQ)
CytomX Therapeutics Inc is an oncology-focused biopharmaceutical company which is engaged in developing antibody therapeutics based on probody technology platform.
Top 10 Gainers:
- SatixFy Communications Ltd. (SATX:NYSEMKT), 96.35%
- Elevate Credit, Inc. (ELVT:NYSE), 68.87%
- Ardelyx, Inc. (ARDX:NASDAQ), 40.98%
- CytomX Therapeutics, Inc. (CTMX:NASDAQ), 32.23%
- Atour Lifestyle Holdings Limited (ATAT:NASDAQ), 30.99%
- XL Group Ltd (XL:NYSE), 30.91%
- NWTN Inc. (NWTN:NASDAQ), 29.75%
- Ampio Pharmaceuticals, Inc. (AMPE:NYSEMKT), 28.32%
- GoHealth Inc. (GOCO:NASDAQ), 26.5%
- Conformis, Inc. (CFMS:NASDAQ), 26.4%